Ledjona Bradshaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ledjona Bradshaw has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- A.M. Crawford
Dallas VA Research Corporation, USA
1 shared publication - Aron Gould-Simon
Dallas Veterans Affairs Medical Center
1 shared publication - Chiarra Thompson
Dallas Veterans Affairs Medical Center
1 shared publication - D. Hoosyhar
VA North Texas Health Care System, USA; University of Texas Southwestern Medical Center, USA
1 shared publication - D.J. Cipher
University of Texas at Arlington, USA
1 shared publication - Francisco Lazaga
Dallas Veterans Affairs Medical Center
1 shared publication
Latest Publications
- 14 December 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (5) , 1335-1342
Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy
Positron emission tomography-computed tomography (PET/CT) occasionally reveals unexpected uptake of 18F-fluorodeoxyglucose (18F-FDG) at the gastroesophageal junction (GEJ). The aim of this study was to determine the importance of unexpected 18F-FDG uptake at the GEJ on PET/CT by correlating this finding with endoscopy results. We reviewed medical records from June 2009 to October 2012 to identify patients in our Veterans Affairs Medical Center who had an esophagogastroduodenoscopy (EGD) performed within 6 months of a PET/CT. Metabolic activity at the GEJ was quantified with standardized uptake values (SUV) and correlated with EGD and histopathology results. A total of 219 patients were identified and assigned to one of five groups based upon EGD findings: esophageal malignancy (n = 34), esophagitis (n = 21), Barrett’s esophagus (n = 8), other non-malignant disorders (n = 5), and normal (n = 151). The mean SUVMax for the groups was 6.72, 2.47, 2.40, 3.48, and 2.06, respectively. SUVMax and SUVMean were significantly higher in the esophageal malignancy group than in all other groups (p Max ≥3.5 was found to predict necessity for EGD with a positive predictive value of 79 %. A SUVMax ≤2.2 yielded a negative predictive value of 86 %. Differentiation between benign and potentially significant disease at the GEJ may be possible with quantification of incidental 18F-FDG uptake at PET/CT. Our results suggest thresholds that may help determine need for further endoscopic evaluation in patients with abnormal metabolic activity at the GEJ.
- 14 December 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (5) , 1335-1342
Significance of 18F-Fluorodeoxyglucose Uptake at the Gastroesophageal Junction: Comparison of PET to Esophagogastroduodenoscopy
Positron emission tomography-computed tomography (PET/CT) occasionally reveals unexpected uptake of 18F-fluorodeoxyglucose (18F-FDG) at the gastroesophageal junction (GEJ). The aim of this study was to determine the importance of unexpected 18F-FDG uptake at the GEJ on PET/CT by correlating this finding with endoscopy results. We reviewed medical records from June 2009 to October 2012 to identify patients in our Veterans Affairs Medical Center who had an esophagogastroduodenoscopy (EGD) performed within 6 months of a PET/CT. Metabolic activity at the GEJ was quantified with standardized uptake values (SUV) and correlated with EGD and histopathology results. A total of 219 patients were identified and assigned to one of five groups based upon EGD findings: esophageal malignancy (n = 34), esophagitis (n = 21), Barrett’s esophagus (n = 8), other non-malignant disorders (n = 5), and normal (n = 151). The mean SUVMax for the groups was 6.72, 2.47, 2.40, 3.48, and 2.06, respectively. SUVMax and SUVMean were significantly higher in the esophageal malignancy group than in all other groups (p Max ≥3.5 was found to predict necessity for EGD with a positive predictive value of 79 %. A SUVMax ≤2.2 yielded a negative predictive value of 86 %. Differentiation between benign and potentially significant disease at the GEJ may be possible with quantification of incidental 18F-FDG uptake at PET/CT. Our results suggest thresholds that may help determine need for further endoscopic evaluation in patients with abnormal metabolic activity at the GEJ.
- 1 November 2014
- Published by Elsevier in Public Health
- Vol. 128 (11) , 985-992
The effects of homelessness on Veterans' health care service use: an evaluation of independence from comorbidities
- 1 November 2014
- Published by Elsevier in Public Health
- Vol. 128 (11) , 985-992
The effects of homelessness on Veterans' health care service use: an evaluation of independence from comorbidities